product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
7721/2
catalog :
7721/2
quantity :
2 mg
price :
231 USD
more info or order :
image
image 1 :

Potent and selective LCK Degrader (PROTAC )
product information
master code :
7721
SKU :
7721/2
product name :
SJ 11646
unit size :
2 mg
description :
Potent and selective LCK Degrader (PROTAC )
target :
Active Degraders
category :
Small Molecules
purity :
98%
observed molecular weight :
746.28
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
SJ 11646 is a potent LCK (lymphocyte-specific protein tyrosine kinase) Degrader (PROTAC DC50 = 0.00838 pM). It comprises Dasatinib (Cat. No. 6793), as the LCK ligand, and a phenyl glutarimide-based cereblon binder. It shows cytotoxicity in LCK-activated T cell acute lymphoblastic leukemia (T-ALL) cell lines and primary leukemia samples in vitro . In vivo , SJ11646 shows anti-leukemic efficacy in patient-derived xenograft models of T-ALL. . LCK antibodies validated for Simple Western (automated Western) instruments and Western Blot also available: Catalog # AF3704 and MAB37041 . . PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license .
top caption :
Potent and selective LCK Degrader (PROTAC )
extended description :
Potent and selective LCK Degrader (PROTAC )
chemical name text :
N-(2-Chloro-6-methylphenyl)-2-((6-(4-(3-(2-(4-(2,6-dioxopiperidin-3-yl)phenoxy)acetamido)propyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide
formula :
C36H40ClN9O5S
formula text :
C36H40ClN9O5S
cas num :
2933135-82-9
USD :
231 USD
product details :
Potent and selective LCK Degrader (PROTAC )
storage :
Store at -20░C
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
browse more products
questions and comments